George Koutsodontis

841 total citations
20 papers, 674 citations indexed

About

George Koutsodontis is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, George Koutsodontis has authored 20 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in George Koutsodontis's work include Cancer Cells and Metastasis (5 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer-related Molecular Pathways (5 papers). George Koutsodontis is often cited by papers focused on Cancer Cells and Metastasis (5 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer-related Molecular Pathways (5 papers). George Koutsodontis collaborates with scholars based in Greece, Austria and United States. George Koutsodontis's co-authors include Dimitris Kardassis, Aristidis Moustakas, Paraskevi Papakosta, Ioannis Tentes, Amanda Psyrri, Αreti Strati, Evi Lianidou, Martha Zavridou, Panagiota Economopoulou and Ioannis Kotsantis and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

George Koutsodontis

20 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George Koutsodontis Greece 12 402 356 201 74 70 20 674
Michael S. McLemore United States 9 224 0.6× 405 1.1× 290 1.4× 58 0.8× 25 0.4× 14 708
Yi-Xin Zeng China 6 318 0.8× 498 1.4× 181 0.9× 65 0.9× 77 1.1× 7 760
John C. Law United States 12 326 0.8× 377 1.1× 141 0.7× 56 0.8× 35 0.5× 16 658
David W. Schoppy United States 11 365 0.9× 489 1.4× 84 0.4× 57 0.8× 45 0.6× 22 692
Hemangini H. Vora India 13 260 0.6× 228 0.6× 100 0.5× 50 0.7× 16 0.2× 35 496
Ambra V. Gualeni Italy 12 194 0.5× 219 0.6× 159 0.8× 78 1.1× 64 0.9× 19 470
Abdo J. Najy United States 14 222 0.6× 367 1.0× 180 0.9× 111 1.5× 56 0.8× 23 618
Laura López-Vicente Spain 4 166 0.4× 265 0.7× 88 0.4× 66 0.9× 23 0.3× 4 480
Yann‐Jang Chen Taiwan 9 134 0.3× 330 0.9× 129 0.6× 68 0.9× 26 0.4× 14 543
Wen‐Son Hsieh Singapore 8 218 0.5× 200 0.6× 91 0.5× 66 0.9× 33 0.5× 9 454

Countries citing papers authored by George Koutsodontis

Since Specialization
Citations

This map shows the geographic impact of George Koutsodontis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Koutsodontis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Koutsodontis more than expected).

Fields of papers citing papers by George Koutsodontis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Koutsodontis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Koutsodontis. The network helps show where George Koutsodontis may publish in the future.

Co-authorship network of co-authors of George Koutsodontis

This figure shows the co-authorship network connecting the top 25 collaborators of George Koutsodontis. A scholar is included among the top collaborators of George Koutsodontis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Koutsodontis. George Koutsodontis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Strati, Αreti, Martha Zavridou, Galatea Kallergi, et al.. (2021). A Comprehensive Molecular Analysis of in Vivo Isolated EpCAM-Positive Circulating Tumor Cells in Breast Cancer. Clinical Chemistry. 67(10). 1395–1405. 19 indexed citations
2.
Zavridou, Martha, Sofia Mastoraki, Αreti Strati, et al.. (2020). Direct comparison of size-dependent versus EpCAM-dependent CTC enrichment at the gene expression and DNA methylation level in head and neck squamous cell carcinoma. Scientific Reports. 10(1). 6551–6551. 40 indexed citations
3.
Trihia, Helen, et al.. (2019). Polymorphous adenocarcinoma of the breast—an exceptionally rare entity: Clinicopathological description of a case and brief review. The Breast Journal. 26(2). 261–264. 10 indexed citations
4.
Economopoulou, Panagiota, George Koutsodontis, Αreti Strati, et al.. (2019). Surrogates of immunologic cell death (ICD) and chemoradiotherapy outcomes in head and neck squamous cell carcinoma (HNSCC). Oral Oncology. 94. 93–100. 13 indexed citations
5.
Economopoulou, Panagiota, George Koutsodontis, Margaritis Avgeris, et al.. (2019). HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study. PLoS ONE. 14(5). e0215984–e0215984. 21 indexed citations
6.
Fostira, Florentia, George Koutsodontis, Elena Vagia, et al.. (2018). Predisposing Germline Mutations in Young Patients With Squamous Cell Cancer of the Oral Cavity. JCO Precision Oncology. 2(2). 1–8. 14 indexed citations
7.
Papadopoulou, Anna, et al.. (2018). Screening for TSC1 and TSC2 mutations using NGS in Greek children with tuberous sclerosis syndrome. European Journal of Paediatric Neurology. 22(3). 419–426. 10 indexed citations
8.
Psyrri, Amanda, Panagiota Economopoulou, Ioannis Kotsantis, et al.. (2018). A phase II window of opportunity study of preoperative olaparib (O) with cisplatin (C) or durvalumab (D) or olaparib alone in in patients with operable squamous cell head and neck carcinoma (HNSCC) (OPHELIA). Annals of Oncology. 29. viii372–viii372. 3 indexed citations
9.
Strati, Αreti, George Koutsodontis, George Papaxoinis, et al.. (2017). Prognostic significance of PD-L1 expression on circulating tumor cells in patients with head and neck squamous cell carcinoma. Annals of Oncology. 28(8). 1923–1933. 158 indexed citations
10.
11.
Zavridou, Martha, Αreti Strati, George Koutsodontis, Amanda Psyrri, & Evi Lianidou. (2017). Abstract 1718: RT-qPCR gene expression analysis of CTCs isolated through an epitope-independent enrichment microfluidic device in patients with head and neck squamous cell carcinoma. Cancer Research. 77(13_Supplement). 1718–1718. 1 indexed citations
12.
Strati, Αreti, George Koutsodontis, Ilias Angelidis, et al.. (2016). Abstract 3108: PD-L1 expressing circulating tumor cells (CTCs) in patients with head and neck squamous cell carcinoma (HNSCC). Cancer Research. 76(14_Supplement). 3108–3108. 3 indexed citations
13.
Koutsodontis, George, Αreti Strati, Margaritis Avgeris, et al.. (2015). PDL1-expressing circulating tumor cells (CTCs) in head and neck squamous cell carcinoma (HNSCC).. Journal of Clinical Oncology. 33(15_suppl). 6018–6018. 3 indexed citations
14.
Pazaitou‐Panayiotou, Kalliopi, Christoforos Giatzakis, George Koutsodontis, et al.. (2010). Identification of Two Novel Mutations in the RET Proto-Oncogene in the Same Family. Thyroid. 20(4). 401–406. 3 indexed citations
15.
Koutsodontis, George, et al.. (2007). A newly detected mutation of the RET protooncogene in exon 8 as a cause of multiple endocrine neoplasia type 2A. HORMONES. 6(2). 152–156. 38 indexed citations
16.
Koutsodontis, George, et al.. (2006). Mutation at codon 804 detected in a Greek kindred by screening of the RET gene in patients with medullary thyroid carcinoma. 11. 1 indexed citations
17.
18.
Koutsodontis, George & Dimitris Kardassis. (2004). Inhibition of p53-mediated transcriptional responses by mithramycin A. Oncogene. 23(57). 9190–9200. 59 indexed citations
19.
Koutsodontis, George, Aristidis Moustakas, & Dimitris Kardassis. (2002). The Role of Sp1 Family Members, the Proximal GC-Rich Motifs, and the Upstream Enhancer Region in the Regulation of the Human Cell Cycle Inhibitor p21WAF-1/Cip1 Gene Promoter. Biochemistry. 41(42). 12771–12784. 69 indexed citations
20.
Koutsodontis, George, Ioannis Tentes, Paraskevi Papakosta, Aristidis Moustakas, & Dimitris Kardassis. (2001). Sp1 Plays a Critical Role in the Transcriptional Activation of the Human Cyclin-dependent Kinase Inhibitor p21 Gene by the p53 Tumor Suppressor Protein. Journal of Biological Chemistry. 276(31). 29116–29125. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael S. McLemore Breakdown of academic impact, for papers by Yi-Xin Zeng Breakdown of academic impact, for papers by John C. Law Breakdown of academic impact, for papers by David W. Schoppy Breakdown of academic impact, for papers by Hemangini H. Vora Breakdown of academic impact, for papers by Ambra V. Gualeni Breakdown of academic impact, for papers by Abdo J. Najy Breakdown of academic impact, for papers by Laura López-Vicente Breakdown of academic impact, for papers by Yann‐Jang Chen Breakdown of academic impact, for papers by Wen‐Son Hsieh
Rankless by CCL
2026